Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse

Insulin-like growth factor-1 (IGF-1) plays several important physiological roles, and IGF-related pathways have been implicated in developmental osteochondral disease and endocrinopathic laminitis. This factor is also a downstream marker of growth hormone activity and its peptide mimetics. Unfortuna...

Full description

Bibliographic Details
Main Authors: Courtnay L. Baskerville, Nicholas J. Bamford, Patricia A. Harris, Simon R. Bailey
Format: Article
Language:English
Published: Tripoli University 2017-03-01
Series:Open Veterinary Journal
Subjects:
Online Access:http://www.openveterinaryjournal.com/2017/Volume%207%20No%201/OVJ-2016-10-062%20C.L.%20Baskerville%20et%20al.pdf
id doaj-54013d0f5a2f4552bb9e934c95f92c06
record_format Article
spelling doaj-54013d0f5a2f4552bb9e934c95f92c062021-10-02T07:04:00ZengTripoli UniversityOpen Veterinary Journal2218-60502218-60502017-03-01717580http://dx.doi.org/10.4314/ovj.v7i1.12Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horseCourtnay L. Baskerville0Nicholas J. Bamford1Patricia A. Harris2Simon R. Bailey3Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Werribee, Victoria, AustraliaFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Werribee, Victoria, AustraliaEquine Studies Group, WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire, UKFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Werribee, Victoria, AustraliaInsulin-like growth factor-1 (IGF-1) plays several important physiological roles, and IGF-related pathways have been implicated in developmental osteochondral disease and endocrinopathic laminitis. This factor is also a downstream marker of growth hormone activity and its peptide mimetics. Unfortunately, previously used assays for measuring equine IGF-1 (radioimmunoassays and ELISAs) are no longer commercially available, and many of the kits on the market give poor results when used on horse samples. The aim of the present study was to compare three different ELISA assays (two human and one horse-specific). Plasma samples from six Standardbreds, six ponies and six Andalusians were used. The human IGF-1 ELISA kit from Immunodiagnostic Systems (IDS) proved to be the most accurate and precise of the three kits; the other two assays gave apparently much lower concentrations, with poor recovery of spiked recombinant human IGF-1 and unacceptably poor intra-assay coefficients of variation (CV). The IDS assay gave an intra-assay CV of 3.59 % and inter-assay CV of 7.31%. Mean percentage recovery of spiked IGF-1 was 88.82%, and linearity and dilutional parallelism were satisfied. The IGF-1 plasma concentrations were 123.21 ±8.24 ng/mL for Standardbreds, 124.95 ±3.69 ng/mL for Andalusians and 174.26 ±1.94 ng/mL for ponies. Therefore of the three assays assessed, the IGF-1 ELISA manufactured by IDS was the most suitable for use with equine plasma samples and may have many useful applications in several different research areas. However, caution should be used when comparing equine studies where different analytical techniques and assays may have been used to measure this growth factor.http://www.openveterinaryjournal.com/2017/Volume%207%20No%201/OVJ-2016-10-062%20C.L.%20Baskerville%20et%20al.pdfEquineInsulin-like growth factorPonies
collection DOAJ
language English
format Article
sources DOAJ
author Courtnay L. Baskerville
Nicholas J. Bamford
Patricia A. Harris
Simon R. Bailey
spellingShingle Courtnay L. Baskerville
Nicholas J. Bamford
Patricia A. Harris
Simon R. Bailey
Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
Open Veterinary Journal
Equine
Insulin-like growth factor
Ponies
author_facet Courtnay L. Baskerville
Nicholas J. Bamford
Patricia A. Harris
Simon R. Bailey
author_sort Courtnay L. Baskerville
title Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
title_short Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
title_full Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
title_fullStr Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
title_full_unstemmed Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
title_sort comparison and validation of elisa assays for plasma insulin-like growth factor-1 in the horse
publisher Tripoli University
series Open Veterinary Journal
issn 2218-6050
2218-6050
publishDate 2017-03-01
description Insulin-like growth factor-1 (IGF-1) plays several important physiological roles, and IGF-related pathways have been implicated in developmental osteochondral disease and endocrinopathic laminitis. This factor is also a downstream marker of growth hormone activity and its peptide mimetics. Unfortunately, previously used assays for measuring equine IGF-1 (radioimmunoassays and ELISAs) are no longer commercially available, and many of the kits on the market give poor results when used on horse samples. The aim of the present study was to compare three different ELISA assays (two human and one horse-specific). Plasma samples from six Standardbreds, six ponies and six Andalusians were used. The human IGF-1 ELISA kit from Immunodiagnostic Systems (IDS) proved to be the most accurate and precise of the three kits; the other two assays gave apparently much lower concentrations, with poor recovery of spiked recombinant human IGF-1 and unacceptably poor intra-assay coefficients of variation (CV). The IDS assay gave an intra-assay CV of 3.59 % and inter-assay CV of 7.31%. Mean percentage recovery of spiked IGF-1 was 88.82%, and linearity and dilutional parallelism were satisfied. The IGF-1 plasma concentrations were 123.21 ±8.24 ng/mL for Standardbreds, 124.95 ±3.69 ng/mL for Andalusians and 174.26 ±1.94 ng/mL for ponies. Therefore of the three assays assessed, the IGF-1 ELISA manufactured by IDS was the most suitable for use with equine plasma samples and may have many useful applications in several different research areas. However, caution should be used when comparing equine studies where different analytical techniques and assays may have been used to measure this growth factor.
topic Equine
Insulin-like growth factor
Ponies
url http://www.openveterinaryjournal.com/2017/Volume%207%20No%201/OVJ-2016-10-062%20C.L.%20Baskerville%20et%20al.pdf
work_keys_str_mv AT courtnaylbaskerville comparisonandvalidationofelisaassaysforplasmainsulinlikegrowthfactor1inthehorse
AT nicholasjbamford comparisonandvalidationofelisaassaysforplasmainsulinlikegrowthfactor1inthehorse
AT patriciaaharris comparisonandvalidationofelisaassaysforplasmainsulinlikegrowthfactor1inthehorse
AT simonrbailey comparisonandvalidationofelisaassaysforplasmainsulinlikegrowthfactor1inthehorse
_version_ 1716857588034830336